DIARECT News

SARS-CoV-2 antigens now available for evaluation!

A prerequisite of developing highly sensitive serological assays for diagnostic purposes is the use of high quality raw materials that reliably enable distinguishing healthy individuals from those infected.

One of the core raw materials of such tests are antigens capable of capturing the patient’s antibodies of interest.

DIARECT now offers SARS-CoV-2 antigens newly developed in the baculovirus/insect cell expression system outperforming reference antigens in different serological assays:

  • SARS-CoV-2 Nucleocapsid (N) Protein (Cat. No. 46000/46001)
  • SARS-CoV-2 Spike (S) Glycoprotein RBD (Cat. No. 46100/46101)

 

More information is available by clicking on the image on the right-hand side or feel free to contact us referring to this at info-dia(at)bbisolutions.com.

Your DIARECT team